Bubble or no bubble, this is the best stock for AI exposure: analyst
Trading in the securities of Charming Medical Ltd (NASDAQ:CHMG) has been halted by the Nasdaq Stock Market, according to a statement released by the company on Friday. The trading halt, announced by Nasdaq on Wednesday, will remain in effect until the company provides additional information requested by the exchange.
This action follows an earlier suspension by the U.S. Securities and Exchange Commission (SEC), which ordered a halt in trading of Charming Medical’s securities from 4:00 a.m. ET on November 12, 2025, through 11:59 p.m. ET on November 25, 2025. The SEC’s order was related to concerns that have not been detailed in the company’s filing.
Charming Medical disclosed that it received an initial information request from Nasdaq on November 12, 2025, in connection with the SEC’s suspension. The company reported that it responded promptly to Nasdaq’s request following a prior Form 6-K filing on November 13, 2025. The company stated it will address any further requests from Nasdaq as needed.
Charming Medical said it is cooperating with the SEC, Nasdaq, and other regulatory authorities. The company also reported that its business operations and financial position have not materially changed as of the date of the filing.
This information is based on a press release statement included in the company’s recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
